SEATTLE, July 9, 2019 /PRNewswire/ -- Swedish Health Services and Volpara Solutions today announced the implementation of Volpara&re

CHAPEL HILL, N.C., July 9, 2019 /PRNewswire/ -- This year, more than 7,000 babies will be born in the United States with a cleft lip and/or palate or other serious craniofacial condition. But the prospects have never been better for these patients to thrive due to advanced medical treatments and interdisciplinary supporting care.

SAN FRANCISCO, July 9, 2019 /PRNewswire/ -- Sensely announced today that it has been named a 2019 Gartner Cool Vendor in Healthcare Artificial Intelligence. According to the report, "AI is a top game-changing technology across healthcare. CIOs should watch these emerging vendors that use innovative approaches to AI in healthcare for beneficial and impactful results.

SOUTH SAN FRANCISCO, Calif., July 9, 2019 /PRNewswire/ -- ORIC Pharmaceuticals, a privately held, clinical-stage oncology company focused on developing cancer treatments that address mechanisms of therapeutic resistance, announced that Lori Friedman, PhD, has been named Chief Scientific Officer. Dr. Friedman will serve on the executive lead

SAN FRANCISCO, July 9, 2019 /PRNewswire/ -- Genstar Capital, a leading private equity firm focused on investments in targeted segments of the financial services, healthcare, industrial technology and software industries, announced today that it has completed the previously announced acquisition of Advarra (the "Company"), a leading provider of compliance soluti

PRINCETON, N.J., July 9, 2019 /PRNewswire/ -- Sandoz Inc. (Sandoz), a Novartis division, today announced the US retail launch of SYMJEPI™ (epinephrine) 0.3 mg and 0.15 mg Injections, making both the adult and pediatric doses immediately available in local pharmacies across the nation.

Consulting Hypnotists Help Ordinary People with Ordinary Problems MERRIMACK, N.H., July 9, 2019 /PRNewswire/ -- The National Guild of Hypnotists will convene their 32nd Annual Convention and Educational Conference on August 9th -11th in

DUBLIN, July 9, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) announced today that the company will present 29 abstracts at the 61st American Headache Society (AHS) Meeting, including one late-breaking podium presentation, five oral podium presentations and 23 poster presentations. The presentations will continue to highlight Allergan's ongoing innovation in t

Nature Research Journal highlights data supporting the therapeutic potential of PMN310 against the toxic oligomer form of amyloid beta, a root cause of Alzheimer's disease TORONTO and CAMBRIDGE, MA, July 9, 2019 /PRNewswire/ - ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focus

CAMBRIDGE, Mass., July 9, 2019 /PRNewswire/ -- GNS Healthcare (GNS), a leading precision medicine company, today announced a $23 million Series D fundraising round, led by Cigna Ventures, a strategic corporate venture capital partner and wholly owned indirect subsidiary of Cigna Corporation (NYSE: CI). Joining the Cigna